Anticardiac Antibodies in Patients with Chronic Pericardial Effusion

Table 1

Demographic data and clinical characteristics of the patients ().

	Patients with chronic pericardial effusion	Control group
	()	()
Female/male	15/15	5/21
Mean age (years ± SD)	57, 29 ± 16,43	65,58 ± 9,21
LVEF (% ± SD)	52,32 ± 12,66	57,0 ± 9,5
Colchicine (%)	30 (100%)	0

LV-EF: left ventricular ejection fraction; SD: standard deviation.